Epidermal growth factor receptor: a promising target in solid tumours
Top Cited Papers
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 30 (1) , 1-17
- https://doi.org/10.1016/j.ctrv.2003.10.002
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growthAnnals of Oncology, 2002
- EGFR and cancer prognosisPublished by Elsevier ,2001
- The EGFR family and its ligands in human cancerEuropean Journal Of Cancer, 2001
- Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell linesInternational Journal of Cancer, 2001
- ZD1839 (???Iressa???)*,??? as an Anticancer AgentDrugs, 2000
- Augmentation of a humanized Anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225Oncogene, 1999
- Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cellsGastroenterology, 1998
- A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancerEuropean Journal Of Cancer, 1996
- Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancerSurgical Oncology, 1992
- Toxicity of ligand and antibody‐directed ricin A‐chain conjugates recognizing the epidermal growth factor receptorJournal of Cellular Physiology, 1987